CHICAGO – Five pivotal studies were released today ahead of the plenary session of the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
CHICAGO – The American Society of Clinical Oncology (ASCO) has completed the first phase in developing several sets of interoperability standards for cancer care data and overcoming the… read more.
A randomized trial comparing robotic with open cystectomy ended early after an interim analysis showed the minimally invasive approach did not reduce complications, according to a researchers.
Antibiotics for acute rhinosinusitis (ARS) are prescribed frequently – especially for younger adult patients and in primary care settings – despite recent consensus guidelines that discourage antibiotic use… read more.
Considered the “silent killer,” high blood pressure affects approximately one billion people worldwide. Among the findings from the Annual Scientific Meeting of the American Society of Hypertension (ASH)… read more.
New research at The University of Nottingham is calling for changes to a government scheme which engages community nurses in the prevention of child abuse and neglect in… read more.
Fibromyalgia, now recognized as a true health syndrome with origins in the central nervous system, has seen many recent evolutions regarding its diagnosis and management which should instil… read more.
FDA Highlights by Bruce Sylvester – Patients with an elevated cardiac risk treated with beta-blockers on the day of or day following non-cardiac, non-vascular surgery have achieved significantly… read more.
Interventions to physicians and patients improve osteoporosis treatment at low cost. Reminding primary care doctors to test at-risk patients for osteoporosis can prevent fractures and reduce health care… read more.
A telemedicine program in under-served urban areas and usual care helped patients improve control of hypertension equally well, researchers reported here.
An infusion of glucose, insulin, and potassium (GIK) to patients on the way to the hospital for acute coronary syndromes won’t stop a myocardial infarction (MI) but may… read more.
Patients in the cangrelor group had a significantly lower rate of the composite of all-cause death, myocardial infarction (MI), ischemia-driven revascularization, and stent thrombosis at 48 hours compared… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
